Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Harvard Bioscience, Inc. - Common Stock (HBIO)

6.1300
+0.2200 (3.72%)
NASDAQ · Last Trade: Apr 18th, 11:04 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Harvard Bioscience, Inc. - Common Stock (HBIO)

Eppendorf AG

Eppendorf AG specializes in laboratory equipment and services for academic and industrial research, primarily in the life sciences sector. Similar to Harvard Bioscience, they produce equipment for sample handling, mixing, and storage. Eppendorf's reputation for quality and reliability, particularly in consumables and everyday laboratory instruments, contributes to a loyal customer base and a competitive advantage. Their focus on precision and customer service helps them maintain a strong position against Harvard Bioscience.

Molecular Devices Corporation

Molecular Devices Corporation specializes in high-performance bioanalytical testing equipment and software solutions for various life sciences applications. Like Harvard Bioscience, they focus on providing researchers with tools for drug discovery and scientific research. The companies serve overlapping markets and often compete by developing innovative instruments that enhance laboratory productivity. Molecular Devices has a strong foothold in high-throughput screening solutions, giving them a competitive edge in automated technologies.

Pall Corporation

Pall Corporation focuses on filtration, separation, and purification technologies, competing with Harvard Bioscience in providing critical solutions for biosciences and pharmaceuticals. The companies intersect in areas related to bioprocessing and laboratory research, with Pall offering unique filtration and fluid management technologies. Pall's strong market presence and specialized filtration expertise grant them a competitive advantage in segments requiring high-efficiency purification systems, making them a key player against Harvard Bioscience.

Sartorius AG

Sartorius AG is a global pharmaceutical and laboratory equipment supplier, and competes with Harvard Bioscience by offering a wide range of products including bioprocess solutions and laboratory instruments. Their advanced technologies in biochemistry and molecular biology provide a significant value proposition to biopharma companies looking for reliable and high-quality equipment. Sartorius's extensive resources for research and development, along with their global reach, create a competitive advantage that positions them strongly within the same market segments as Harvard Bioscience.

Thermo Fisher Scientific Inc. TMO +2.05%

Thermo Fisher Scientific Inc. is recognized as a leader in the analytical instruments and life sciences sector, offering a wide range of products that compete with those produced by Harvard Bioscience. They provide advanced laboratory instruments, reagents, and consumables catering to numerous verticals, including pharmaceuticals and academia. Thermo Fisher's established market presence, extensive product portfolio, and robust support services give them a strong competitive edge over Harvard Bioscience, making them a formidable rival in the scientific community.